Central serous chorioretinopathy

What is central serous chorioretinopathy?

• It is the fourth retinal disease that threats our vision.
• If you experience blurred vision, perception of a central spot, straight lines that seem bent or you have troubles in focusing when reading, you should go to the ophthalmologist in order to be diagnosed.
• It is more frequent in young men, even though women, usually at a more advanced age, may also suffer it.
• Stress, pregnancy and corticoids intake, as well as other hormonal disorders, are the main risk factors of the disease.
• Its acute form does not require in most of the cases a treatment, as it resolves spontaneously in around three months, but the chronic form does indeed require a treatment.

In case of blurred vision, perception of a central spot, straight lines seem bent or you have troubles in focusing when reading, you should go to the ophthalmologist. It could be a central serous chorioretinopaty or other retinal problems. Stress, pregnancy or corticoids intake are some of its risk factors.

Central serous chorioretinopathy is not a frequent disease, but it is important to consider it because it is the forth retinal disease that most threatens our vision behind age-related macular degeneration, vascular occlusions or diabetic macular edema.

It is a disease which is usually diagnosed among young male patients, between their thirties or forties, although according to the latest population studies, women may also suffer it. In such cases, it often appears at a more advanced age.

This disease requires a good differential diagnosis, which means it is important to differentiate the disease from other similar diseases, such as polypoidal vasculopathy (a type of age-related macular degeneration), the Vogt-Koyanagi-Harada disease (a type of uveitis), benign tumors (such as nevus or hemangiomas), or more dangerous and malign tumors (such as melanoma or lymphoma).

Causes

In spite of the high number of studies and interest shown regarding this disease, it is not known for sure. There are several theories. One of the most important ones and with a more solid scientific base is a theory based on the hormonal imbalance, for which glucocorticoids act like mineralocorticoids and cause an inflammation in the choroid, a vascular tissue that nourishes our eyes and is located under the retina.

When there is a vascular inflammation, vessels dilate and become permeable. If there is an increase in blood vessels permeability, fluid leaks out and accumulates on the choroid and is retained by the pigment epithelium. But over time, this barrier becomes inefficient and the fluid runs under the retina. This is how central serous chorioretinopathy occurs.

• One of the factors is hormonal imbalance. This factor has been known for a long time. It affects specially young men in management positions who suffer from work stress.
• Moreover, the intake of corticoids is also a risk factor, regardless of whether it is a pomade for skin, an inhalator for asthmatic patients or corticoids administered intravenously. Any intake of such medicines may imbalance the hormonal state and lead to a central serous chorioretinopathy.
• Other hormonal alterations, such as Cushing syndrome or pregnancy, during which many hormonal imbalances occur, may lead to this disease.

Besides factors directly related to hormones, other risk factors have been studied:

• Presence of helicobacter pylori, a bacteria which can live inside the stomach and cause an inflammation on its tissue.
• Treatments for depression, anxiety, insomnia (sleeping troubles) may also trigger a central serous chorioretinopathy.
• Patients with cardiovascular risk factors, such as hypertension, ictus or infarction are also at a higher risk of suffering the disease, according to new population studies.

Treatment

The treatment will depend on the type of central serous chorioretinopathy.

Acute form

In case of an acute central serous chorioretinopathy, it is not usually recommended to apply any treatment, as in 80-90% of cases, it resolves on its own. The only thing we need to do is to monitor the patient and perform the necessary regular controls.

Chronic form

In case the disease does not resolve on its own, is recurrent or the patient has very low vision or requires good vision for professional matters, a treatment must be planned.

• The disease may be associated to corticoids intake, reason why the use of such medicines will need to be stopped after consulting with the specialist who prescribed them.
• We may also try to reduce the level of stress, even though it is difficult, but patients usually improve practising sports or yoga and trying to see their lives differently.
• One of the most used treatments, that has a more solid base is photo-dynamic therapy. This treatment has an efficiency of approximately 86% and it decreases the disease recurrence. In 40% of cases, the disease may appear again, reason why using a treatment that decreases such changes is important. Photo-dynamic therapy is an invasive treatment, as a photosensitive substance is injected. This helps us direct the laser treatment only to the affected area, that is where the substance accumulates in the eye.

Other types of treatments that are currently being studied include the use of micropulse laser. It seems a good alternative, although the study results are still to be confirmed.

Patients are also treated with anti-VEGF intravitreous injections of a substance known as vascular endothelial growth factor, whose use is known as a treatment against ARMD or diabetic macular edema. This drug is currently widely used in ophthalmology.

There are also pharmacological treatments with still non proved scientific based, but the first studies performed reveal its possible efficacy. These are mineralocorticoid inhibitors, such as epleronone or spironolactone.